跳至主要内容
临床试验/NCT01525797
NCT01525797已完成不适用

Immunomonitoring of Transplant Patients

Baylor Research Institute1 个研究点 分布在 1 个国家目标入组 221 人开始时间: 2002年10月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
221
试验地点
1
主要终点
Identify signatures predictive of graft rejection or tolerance.

研究概览

简要总结

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

详细描述

The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
17 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Received a liver Transplant

排除标准

  • Received Multiple Organ Transplant

研究组 & 干预措施

Control

Rejection

结局指标

主要结局

Identify signatures predictive of graft rejection or tolerance.

时间窗: 2 years

Analyze the pattern of gene expression in patients undergoing solid organ transplantation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Blood Draw Study for Liver Transplant Patients | 临床试验